Exact Mass: 417.157

2-N,6-N-Bis(2,3-dihydroxybenzoyl)-L-lysine amide

C20H23N3O7 (417.1536)

Gabexate mesylate

C17H27N3O7S (417.157)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants

DTXSID40930256

C20H29Cl2NO4 (417.1474)

(1S,4R)-passicapsin

C18H27NO10 (417.1635)

Natalinine

C25H23NO5 (417.1576)

3-[O-β-D-quinovopyranosyl-(1?2)-β-D-quinovopyranosyl]-2-acetyl-pyrrole|astebatherioside C

C18H27NO10 (417.1635)

haterumaimide E

C20H29Cl2NO4 (417.1474)

Met His Met

C16H27N5O4S2 (417.1504)

Phe Asp His

C19H23N5O6 (417.1648)

Phe His Asp

C19H23N5O6 (417.1648)

His Phe Asp

C19H23N5O6 (417.1648)

His Met Met

C16H27N5O4S2 (417.1504)

Met Met His

C16H27N5O4S2 (417.1504)

Asp His Phe

C19H23N5O6 (417.1648)

Gly Asn Asn Asn

C14H23N7O8 (417.1608)

His Asp Phe

C19H23N5O6 (417.1648)

Asp Phe His

C19H23N5O6 (417.1648)

Asn Gly Asn Asn

C14H23N7O8 (417.1608)

Asn Asn Gly Asn

C14H23N7O8 (417.1608)

Asn Asn Asn Gly

C14H23N7O8 (417.1608)

Lys-Tyr-OH

C20H23N3O7 (417.1536)

3-N-FMOC-3-(3-METHOXYPHENYL)PROPIONIC ACID

C25H23NO5 (417.1576)

4-(DIFLUOROMETHYL)-1-FLUOROBENZENE

C25H23NO5 (417.1576)

N-Fmoc-(2S,3S)-3-Amino-2-hydroxy-4-phenyl-butyric acid

C25H23NO5 (417.1576)

Fmoc-D-phe(4-OCH3)-OH

C25H23NO5 (417.1576)

Fmoc-(R)-3-Amino-3-(2-methoxyphenyl)-propionic acid

C25H23NO5 (417.1576)

fmoc-(r)-3-amino-3-(3-methoxy-phenyl)-propionic acid

C25H23NO5 (417.1576)

Fmoc-beta-(R)-4-methoxyphenylalanine

C25H23NO5 (417.1576)

Fmoc-Ser(Bzl)-OH

C25H23NO5 (417.1576)

1-(2-METHOXYPHENYL)-1H-BENZOIMIDAZOLE

C19H29Cl2N3O3 (417.1586)

Fmoc-4-Methoxy-L-phenylalanine

C25H23NO5 (417.1576)

Fmoc-D-Ser(Bzl)-OH

C25H23NO5 (417.1576)

1-benzyl-3,4-bis(1H-indol-3-yl)pyrrole-2,5-dione

C27H19N3O2 (417.1477)

Fmoc-L-Ser-Obzl

C25H23NO5 (417.1576)

fmoc-(s)-3-amino-3-(2-methoxy-phenyl)-propionic acid

C25H23NO5 (417.1576)

fmoc-(s)-3-amino-3-(3-methoxy-phenyl)-propionic acid

C25H23NO5 (417.1576)

4-(1-Methylethyl)-2-(tributylstannyl)-Thiazole

C18H35NSSn (417.1512)

Chloroquine sulfate

C18H28ClN3O4S (417.1489)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018501 - Antirheumatic Agents C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Xaliproden hydrochloride

C24H23ClF3N (417.1471)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists C26170 - Protective Agent > C1509 - Neuroprotective Agent Xaliproden hydrochloride (SR57746A) is a potent, selective and orally active agonist of 5-HT1A receptor, shows a high affinity for 5-HT1A specific binding sites in the rat hippocampus (IC50=3 nM). Xaliproden hydrochloride is also a selective antagonist of dopamine D2 receptor, has moderate affinity (IC50=0.1-1 μM). Xaliproden hydrochloride exhibits anti-depression and anti-anxiety effects, and it may possess therapeutic potential for the research of neurodegenerative diseases[1][2][3].

Fmoc-HomoTyr-OH

C25H23NO5 (417.1576)

(S)-Fmoc-α-Me-Tyr-OH

C25H23NO5 (417.1576)

Daidzein-D3-7-O-b-D-glucopyranoside

C22H19O8D3 (417.1503)

9-alpha-D-Glucopyranosyl-N-[(2-methoxyphenyl)methyl]-9H-purin-6-amine

C19H23N5O6 (417.1648)

GABEXATE MESILATE

C17H27N3O7S (417.157)

(S)- FMOC-2-METHOXYPHENYLALANINE

C25H23NO5 (417.1576)

Amonafide L-malate

C20H23N3O7 (417.1536)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

(1R,4R,6R,7R,11Z)-4-[(1R)-1-chloroethyl]-4,7-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H28ClNO7 (417.1554)

Nivaquine

C18H28ClN3O4S (417.1489)

D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018501 - Antirheumatic Agents

N-[2-[4-[3-(4-amino-5-chloro-2-methoxyphenyl)-3-oxopropyl]piperidin-1-yl]ethyl]methanesulfonamide

C18H28ClN3O4S (417.1489)

2-[2-(2-chlorophenyl)-1-benzimidazolyl]-N-(2,6-diethylphenyl)acetamide

C25H24ClN3O (417.1608)

1-(4-(1H-pyrrol-1-yl)phenyl)-3-methyl-8-(pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one

C26H19N5O (417.159)

N-[(2S,3S,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-2-carboxamide

C21H21F2N3O4 (417.15)

N-[(2R,3R,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)

N-[(2R,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]pyridine-2-carboxamide

C21H21F2N3O4 (417.15)

N-[(2R,3S,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)

N-[(2S,3S,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)

2-[(2S,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

2-[(2S,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

2-[(2R,3R,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

(1R,2aS,8bS)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)

N-[(2S,3R,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)

N-[(2S,3R,6S)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)

N-[(2R,3S,6R)-6-[2-[(3,5-difluorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-3-yl]-2-pyridinecarboxamide

C21H21F2N3O4 (417.15)

2-[(2R,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

2-[(2S,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

2-[(2R,3S,6R)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

2-[(2R,3R,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

2-[(2S,3S,6S)-3-[[(2,5-difluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-phenylacetamide

C21H21F2N3O4 (417.15)

(1R,2aR,8bR)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)

(1S,2aS,8bS)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)

(1S,2aR,8bR)-N-(2,5-difluorophenyl)-1-(hydroxymethyl)-2-(2-methoxy-1-oxoethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C21H21F2N3O4 (417.15)

(1R,5S)-N-(2-chlorophenyl)-7-[4-(3-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C25H24ClN3O (417.1608)

(1S,5R)-N-(4-chlorophenyl)-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C25H24ClN3O (417.1608)

His-Phe-Asp

C19H23N5O6 (417.1648)

Asp-His-Phe

C19H23N5O6 (417.1648)

Asp-Phe-His

C19H23N5O6 (417.1648)

Met-Met-His

C16H27N5O4S2 (417.1504)

Phe-Asp-His

C19H23N5O6 (417.1648)

His-Asp-Phe

C19H23N5O6 (417.1648)

His-Met-Met

C16H27N5O4S2 (417.1504)

Met-His-Met

C16H27N5O4S2 (417.1504)

Phe-His-Asp

C19H23N5O6 (417.1648)

desacetyldoronine

C19H28ClNO7 (417.1554)

A pyrrolizine alkaloid that is produced by a hybrid species of Jacobaea.

MS48107

C23H20FN5O2 (417.1601)

MS48107 is a potent and selective positive allosteric modulator of G protein-coupled receptor 68 (GPR68). MS48107 is selective for GPR68 over the closely related proton GPCRs, neurotransmitter transporters, and hERG ion channels. MS48107 can readily cross the blood-brain barrier (BBB) in mice[1].

Tyroserleutide (hydrochloride)

C18H28ClN3O6 (417.1667)

Tyroserleutide hydrochloride, isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2].

(1s,4r)-4-{[(2r,4s,5r,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopent-2-ene-1-carbonitrile

C18H27NO10 (417.1635)

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8ar)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)

(1s,6s,7s)-4-(1-chloroethyl)-4,7-dihydroxy-6,7,14-trimethyl-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-ene-3,8,17-trione

C19H28ClNO7 (417.1554)

3-[2-(6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)

(3r)-3-[(1s)-2-[(1r,3s,4ar,6r,7r,8as)-6,7-dichloro-3-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-1-hydroxyethyl]-5-hydroxy-3,4-dihydropyrrol-2-one

C20H29Cl2NO4 (417.1474)